Preterm delivery of a live infant · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes preterm delivery of a live infant compared with placebo (very low certainty).
1 finding from 1 review
Intrauterine growth restriction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes intrauterine growth restriction compared with placebo (very low certainty).
1 finding from 1 review
Adverse events in the child ‐ Congenital malformations · women with persistent antiphospholipid antibodies and recurrent pregnancy loss
It is very uncertain whether aspirin changes adverse events in the child ‐ Congenital malformations compared with placebo (very low certainty).
1 finding from 1 review
Serious neonatal morbidity
It is very uncertain whether cervical cerclage in combination with antibiotics and tocolytics changes serious neonatal morbidity (Reported in Miller 2014 as 'composite… compared with cervical cerclage alone (very low certainty).
1 finding from 1 review
Perinatal loss: all ‐ including miscarriages and stillbirth (Note: data not available for neonatal death)
It is very uncertain whether cervical cerclage in combination with antibiotics and tocolytics changes perinatal loss: all ‐ including miscarriages and stillbirth (Note:… compared with cervical cerclage alone (very low certainty).
1 finding from 1 review
Baby discharged home healthy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death of the baby before discharge: neonatal death
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stillbirth (death after 24 weeks inutero)
1 finding from 1 review
Preterm birth less than 34 weeks' gestation
It is very uncertain whether cervical cerclage in combination with antibiotics and tocolytics changes preterm birth < 34 completed weeks of pregnancy compared with cervical cerclage alone (very low certainty).
1 finding from 1 review
Hypertensive disorders (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) · women with gestational diabetes mellitus
Probiotic showed no clear difference in hypertensive disorders (including pre‐eclampsia, pregnancy‐induced… compared with placebo (low certainty).
1 finding from 1 review
Composite outcome in infant (death, shoulder dystocia, nerve palsy, bone fracture) · women with gestational diabetes mellitus
1 finding from 1 review
Neurosensory disability · women with gestational diabetes mellitus
1 finding from 1 review
Neonatal hypoglycaemia requiring treatment (variously defined) · women with gestational diabetes mellitus
Probiotic showed no clear difference in neonatal hypoglycaemia requiring treatment (variously defined) compared with placebo (low certainty).
1 finding from 1 review
Adiposity · women with gestational diabetes mellitus
1 finding from 1 review
Diabetes(type1 or type2) or impaired glucose tolerance (child/adult) · women with gestational diabetes mellitus
1 finding from 1 review
Development of type 2 diabetes · women with gestational diabetes mellitus
1 finding from 1 review
Caesarean birth№ of participants: 159(2 RCTs) · women with gestational diabetes mellitus
Probiotic showed no clear difference in mode of birth (caesarean) compared with placebo (low certainty).
1 finding from 1 review
Induction of labour · women with gestational diabetes mellitus
It is very uncertain whether probiotic changes induction of labour compared with placebo (very low certainty).
1 finding from 1 review
Perineal trauma · women with gestational diabetes mellitus
1 finding from 1 review
Postnatal weight retention or return to pre‐pregnancy weight · women with gestational diabetes mellitus
1 finding from 1 review